MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Authors
Keywords
-
Journal
Oncogenesis
Volume 10, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-26
DOI
10.1038/s41389-021-00309-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- (2020) Maria V. Yusenko et al. CANCER LETTERS
- ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
- (2020) Mattias K. Andersson et al. Oncogenesis
- Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2
- (2020) Ken Morita et al. CELL
- Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH
- (2020) Yu-Chao Xiong et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential
- (2020) Rachel Bayley et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
- (2019) Hui Qin et al. OncoTargets and Therapy
- The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity
- (2019) Sanjivan Gautam et al. NATURE IMMUNOLOGY
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
- (2019) Börje Ljungberg et al. EUROPEAN UROLOGY
- cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
- (2019) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing
- (2019) Jianming Pei et al. MODERN PATHOLOGY
- MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells
- (2019) Ren-Ming Yang et al. ONCOGENE
- YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells
- (2019) Teng Wei et al. ONCOGENE
- MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia
- (2019) Martin J. Magers et al. MODERN PATHOLOGY
- The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes
- (2019) Grit Pattschull et al. Cell Reports
- Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
- (2019) Annika K. Wefers et al. ACTA NEUROPATHOLOGICA
- Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer
- (2019) Firoz Ahmed Frontiers in Oncology
- Will new agents impact survival in AML?
- (2019) Jacob M. Rowe BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
- (2019) Yu Gao et al. Scientific Reports
- Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts
- (2018) Liubov Kyrpychova et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts
- (2018) Yuki Togashi et al. MODERN PATHOLOGY
- MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis
- (2018) Jianli Chen et al. ONCOLOGY RESEARCH
- Peptidomimetic blockade of MYB in acute myeloid leukemia
- (2018) Kavitha Ramaswamy et al. Nature Communications
- MuvB: A Key to Cell Cycle Control in Ovarian Cancer
- (2018) Audra N. Iness et al. Frontiers in Oncology
- High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma
- (2018) Z. Guan et al. Current Research in Translational Medicine
- Regulation of the master regulator FOXM1 in cancer
- (2018) Guo-Bin Liao et al. Cell Communication and Signaling
- Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma
- (2018) Joseph Mandelbaum et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb
- (2018) Audra N. Iness et al. ONCOGENE
- Acute myeloid leukemia: 2019 update on risk-stratification and management
- (2018) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization
- (2018) Eugen Werwein et al. NUCLEIC ACIDS RESEARCH
- B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
- (2017) Yuelei Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of b-Myb and miRNA34a expression
- (2017) Yu-Jin Lee et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors
- (2017) Stéphane Ducassou et al. JOURNAL OF PATHOLOGY
- MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB -NFIB fusion gene
- (2017) Jisun Kim et al. JOURNAL OF PATHOLOGY
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma
- (2017) Ranjie Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy
- (2017) Patrick Wolter et al. Oncotarget
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
- (2016) Ibrahim Qaddoumi et al. ACTA NEUROPATHOLOGICA
- c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/ -Catenin/Axin2 Pathway
- (2016) Y. Li et al. CANCER RESEARCH
- A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
- (2016) Emiliano Calvo et al. CLINICAL CANCER RESEARCH
- A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
- (2016) L.D. Locati et al. EUROPEAN JOURNAL OF CANCER
- Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells
- (2016) Sagar Uttarkar et al. MOLECULAR CANCER THERAPEUTICS
- An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
- (2016) Yotam Drier et al. NATURE GENETICS
- MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
- (2016) Pratiti Bandopadhayay et al. NATURE GENETICS
- Acute myeloid leukemia in children: Current status and future directions
- (2016) Takashi Taga et al. PEDIATRICS INTERNATIONAL
- CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression
- (2016) Partha Mitra et al. Oncotarget
- MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis
- (2016) Tiziana Pierini et al. Molecular Cytogenetics
- Biochemical Properties and Biological Functions of FET Proteins
- (2015) Jacob C. Schwartz et al. Annual Review of Biochemistry
- Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
- (2015) Sagar Uttarkar et al. BLOOD
- MYB is a novel regulator of pancreatic tumour growth and metastasis
- (2015) Sanjeev K Srivastava et al. BRITISH JOURNAL OF CANCER
- IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
- (2015) Lukas F. Mager et al. JOURNAL OF CLINICAL INVESTIGATION
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis
- (2015) D. Cheasley et al. MOLECULAR CANCER RESEARCH
- Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300
- (2015) S. Uttarkar et al. MOLECULAR CANCER THERAPEUTICS
- Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
- (2015) K. J. Brayer et al. Cancer Discovery
- Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop
- (2015) Oncotarget
- Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
- (2014) D. R. Pattabiraman et al. BLOOD
- Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
- (2014) Daruka Mahadevan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers
- (2014) Ralph Stadhouders et al. JOURNAL OF CLINICAL INVESTIGATION
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
- (2014) M. R. Mansour et al. SCIENCE
- Molecular classification of breast cancer
- (2014) Darina Vuong et al. VIRCHOWS ARCHIV
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
- (2013) Kiyoshi Okamoto et al. CANCER LETTERS
- Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients
- (2013) Óscar Fuster et al. LEUKEMIA RESEARCH
- The mutational landscape of adenoid cystic carcinoma
- (2013) Allen S Ho et al. NATURE GENETICS
- Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance
- (2013) Hongtai Zhang et al. NATURE GENETICS
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1
- (2013) L. A. Ramkissoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy
- (2013) Stefan Heinrichs et al. eLife
- Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb
- (2012) Christin F. Down et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance
- (2012) S. K. Srivastava et al. CARCINOGENESIS
- The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
- (2012) S. Sadasivam et al. GENES & DEVELOPMENT
- MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
- (2012) M Clarke et al. LEUKEMIA
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- Duplication and maintenance of the Myb genes of vertebrate animals
- (2012) C. J. Davidson et al. Biology Open
- Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants
- (2011) C. Quelen et al. BLOOD
- Identification and Regulation of c-Myb Target Genes in MCF-7 Cells
- (2011) Anita M Quintana et al. BMC CANCER
- Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome
- (2011) Hong Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- MYB Is Essential for Mammary Tumorigenesis
- (2011) R. Yu Miao et al. CANCER RESEARCH
- A-MYB (MYBL1) transcription factor is a master regulator of male meiosis
- (2011) E. Bolcun-Filas et al. DEVELOPMENT
- Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
- (2011) Diego F. Calvisi et al. HEPATOLOGY
- Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft
- (2011) M. Pia Morelli et al. JOURNAL OF CLINICAL ONCOLOGY
- The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma
- (2011) A Fehr et al. JOURNAL OF PATHOLOGY
- In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels
- (2011) E Belloni et al. LEUKEMIA
- Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms
- (2011) Louis B Brill et al. MODERN PATHOLOGY
- GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb
- (2011) Fangfang Zhou et al. MOLECULAR BIOLOGY OF THE CELL
- Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb
- (2011) Liang Zhao et al. NUCLEIC ACIDS RESEARCH
- Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance
- (2010) Y. Mitani et al. CLINICAL CANCER RESEARCH
- MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells
- (2010) Michael Papetti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype
- (2010) Maddalena Frau et al. JOURNAL OF HEPATOLOGY
- Survival and long-term health and cognitive outcomes after low-grade glioma
- (2010) Gregory T. Armstrong et al. NEURO-ONCOLOGY
- The C-MYB story--is it definitive?
- (2010) J. S. Lipsick PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-Myb is Critical for Proper DNA Duplication During an Unperturbed S Phase in Mouse Embryonic Stem Cells
- (2010) Maëlle Lorvellec et al. STEM CELLS
- RNA-Binding Protein Quaking, a Critical Regulator of Colon Epithelial Differentiation and a Suppressor of Colon Cancer
- (2009) Guodong Yang et al. GASTROENTEROLOGY
- Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb
- (2009) Carola Wilczek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells
- (2009) A S Knight et al. ONCOGENE
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
- (2009) M. Persson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer
- (2008) Benjamin B. Williams et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Alternative RNA Splicing Produces Multiple Forms of c-Myb with Unique Transcriptional Activities
- (2008) J. P. O'Rourke et al. MOLECULAR AND CELLULAR BIOLOGY
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
- B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells
- (2008) Kirill V. Tarasov et al. PLoS One
- c-Myb Is Required for Neural Progenitor Cell Proliferation and Maintenance of the Neural Stem Cell Niche in Adult Brain
- (2007) Jordane Malaterre et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation